EUCTR2014-005130-55-SE进行中（未招募）1 期
HD21 for advanced stages: Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD. - HD21 (advanced stage)
niversity of Cologne0 个研究点目标入组 1,500 人开始时间: 2017年12月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histologically proven classical Hodgkin lymphoma
- •First diagnosis, no previous treatment, 18 to 60 years of age
- •Stage IIB with large mediastinal mass and/or extranodal lesions, stage III or IV
- •Elderly cohort:
- •Age 61-75 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1500
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 85
排除标准
- •Composite lymphoma or nodular lymphocyte-predominant Hodgkin lymphoma
- •Previous malignancy (exceptions: basalioma, carcinoma in situ of the cervix uteri, completely resected melanoma TNMpT1)
- •Prior chemotherapy or radiotherapy
- •Concurrent disease which precludes protocol treatment
- •Pregnancy, lactation
- •Non-Compliance
研究者
相似试验
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatment of advanced stage Hodgkin lymphomaTreatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-005130-55-DEniversity of Cologne1,500
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatmend of advanced stage Hodgkin lymphomaEUCTR2014-005130-55-DKniversity of Cologne1,500
已完成
3 期
HD212024-518022-33-00University Of Cologne1,320
招募中
3 期
HD21 for advanced stages: Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD; a randomized phase III trialHodgkin's disease10025319malignant lymphomaNL-OMON50640niversitly of Cologne100
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatmend of advanced stage Hodgkin lymphomaTreatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-005130-55-NLniversity of Cologne1,500